An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy
NCT02065856
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen
Interventions
BIOLOGICAL:
AVANZ Salsola
Sponsor
ALK-Abelló A/S